End-of-day quote
Shenzhen S.E.
23:00:00 12/05/2024 BST
|
5-day change
|
1st Jan Change
|
8.33
CNY
|
-0.24%
|
|
-2.34%
|
+10.33%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,219
|
6,124
|
4,533
|
11,941
|
6,943
|
7,190
|
Enterprise Value (EV)
1 |
5,553
|
8,126
|
6,239
|
12,339
|
6,576
|
6,746
|
P/E ratio
|
22.7
x
|
30.4
x
|
24.8
x
|
7.39
x
|
7.96
x
|
9.85
x
|
Yield
|
2.96%
|
1.56%
|
2.1%
|
2.37%
|
4.12%
|
-
|
Capitalization / Revenue
|
0.55
x
|
0.97
x
|
0.74
x
|
1.27
x
|
0.77
x
|
0.88
x
|
EV / Revenue
|
0.96
x
|
1.29
x
|
1.02
x
|
1.31
x
|
0.73
x
|
0.82
x
|
EV / EBITDA
|
10.4
x
|
11.8
x
|
10
x
|
4.92
x
|
4.19
x
|
5
x
|
EV / FCF
|
12.5
x
|
13.2
x
|
12.2
x
|
8.53
x
|
6.41
x
|
17.1
x
|
FCF Yield
|
7.98%
|
7.57%
|
8.21%
|
11.7%
|
15.6%
|
5.83%
|
Price to Book
|
1.23
x
|
2.24
x
|
1.6
x
|
2.77
x
|
1.39
x
|
1.31
x
|
Nbr of stocks (in thousands)
|
952,365
|
952,365
|
952,365
|
942,460
|
952,365
|
952,365
|
Reference price
2 |
3.380
|
6.430
|
4.760
|
12.67
|
7.290
|
7.550
|
Announcement Date
|
19/04/19
|
24/04/20
|
23/04/21
|
21/04/22
|
27/04/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,806
|
6,315
|
6,099
|
9,413
|
9,045
|
8,215
|
EBITDA
1 |
535.1
|
690.9
|
622.4
|
2,509
|
1,570
|
1,349
|
EBIT
1 |
218
|
298.6
|
225.5
|
2,098
|
1,146
|
900.1
|
Operating Margin
|
3.75%
|
4.73%
|
3.7%
|
22.29%
|
12.67%
|
10.96%
|
Earnings before Tax (EBT)
1 |
181.8
|
248.3
|
214.7
|
2,147
|
1,117
|
959
|
Net income
1 |
142
|
201.6
|
182.6
|
1,633
|
872.1
|
729.7
|
Net margin
|
2.45%
|
3.19%
|
2.99%
|
17.35%
|
9.64%
|
8.88%
|
EPS
2 |
0.1491
|
0.2116
|
0.1918
|
1.715
|
0.9157
|
0.7662
|
Free Cash Flow
1 |
443
|
615.2
|
511.9
|
1,447
|
1,026
|
393.6
|
FCF margin
|
7.63%
|
9.74%
|
8.39%
|
15.37%
|
11.35%
|
4.79%
|
FCF Conversion (EBITDA)
|
82.79%
|
89.05%
|
82.25%
|
57.69%
|
65.37%
|
29.17%
|
FCF Conversion (Net income)
|
311.89%
|
305.24%
|
280.32%
|
88.6%
|
117.66%
|
53.94%
|
Dividend per Share
2 |
0.1000
|
0.1000
|
0.1000
|
0.3000
|
0.3000
|
-
|
Announcement Date
|
19/04/19
|
24/04/20
|
23/04/21
|
21/04/22
|
27/04/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,334
|
2,002
|
1,706
|
398
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
367
|
445
|
Leverage (Debt/EBITDA)
|
4.362
x
|
2.898
x
|
2.741
x
|
0.1586
x
|
-
|
-
|
Free Cash Flow
1 |
443
|
615
|
512
|
1,447
|
1,026
|
394
|
ROE (net income / shareholders' equity)
|
5.35%
|
7.36%
|
6.13%
|
44.7%
|
18.1%
|
13.2%
|
ROA (Net income/ Total Assets)
|
2.13%
|
2.83%
|
2%
|
16.9%
|
8.71%
|
6.76%
|
Assets
1 |
6,674
|
7,122
|
9,110
|
9,677
|
10,009
|
10,794
|
Book Value Per Share
2 |
2.760
|
2.870
|
2.980
|
4.580
|
5.240
|
5.750
|
Cash Flow per Share
2 |
0.2700
|
0.3400
|
0.4500
|
0.3500
|
0.4300
|
0.6000
|
Capex
1 |
57
|
50.8
|
89.8
|
199
|
65.9
|
228
|
Capex / Sales
|
0.98%
|
0.8%
|
1.47%
|
2.11%
|
0.73%
|
2.77%
|
Announcement Date
|
19/04/19
|
24/04/20
|
23/04/21
|
21/04/22
|
27/04/23
|
25/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +10.33% | 1.1B | | +6.15% | 105B | | -4.43% | 64.68B | | +60.48% | 43.21B | | +16.73% | 39.33B | | +6.69% | 32.99B | | +11.97% | 20.09B | | +13.41% | 17.05B | | +25.44% | 15.96B | | +7.25% | 14.69B |
Other Commodity Chemicals
|